Obesity is a disease but not diagnosed with BMI alone, says Lancet Global Commission
BMI can be used to diagnose obesity but only in conjunction with other measures of body fat, according to a landmark international statement. A Lancet…
Tag: weight
Pharma pushes for GLP-1 receptor agonist to be listed on the PBS for obesity
Pharmaceutical giant Eli Lilly is readying a PBAC application for tirzepatide, which if successful, would become the first GLP-1 receptor agonist publicly funded for obesity…
Is Ozempic the new ‘miracle drug’ for patients with osteoarthritis-related knee pain?
The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood…
Telehealth corporate’s founders hit rich list with $150 million fortune
Three founders of Eucalyptus, the telehealth corporate known for prescribing semaglutide at scale, have accrued fortunes of $52 million each, according to the Australian Financial…
Patients with PCOS want more than weight-loss advice: Aussie review
A systematic review of PCOS treatment shows that doctors and patients agree on one thing: the current approach is not working. The Australian authors evaluated…
As an endocrinologist specialising in obesity, I’m calling for a major rethink on how we manage this disease
For years, Andrew refused to see a GP. If he developed an infection, he’d often rely on his wife’s repeat antibiotic prescriptions. × Welcome to…
‘Other drugs are available’: Compounded semaglutide ban having no impact, claim telehealth corporates
Doctors at telehealth corporates have moved to Wegovy and Mounjaro as weight loss treatments ahead of today’s ban on semaglutide compounding. The Federal Government announced…
Novo Nordisk finally launches semaglutide pen indicated for weight loss in Australia
Novo Nordisk’s subcutaneous weight-loss drug Wegovy will hit Australian shelves this month, two years after it received TGA approval. The once-weekly injectable semaglutide formulation will…
How Novo Nordisk lobbied AHPRA and the TGA to get compounded semaglutide banned
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
Govt to ban semaglutide compounding from October amid patient safety fears
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October. About 20,000 patients are currently using compounded semaglutide for…
